ABSTRACT
DNA vaccination has generated great interest as a potential disease-modifying or curative treatment for atopic disorders, in part, because of its promotion of antigen (Ag)-specific type I CD4
effector T cells (Th1).
DNA vaccination has generated great interest as a potential disease-modifying or curative treatment for atopic disorders, in part, because of its promotion of antigen (Ag)-specific type I CD4
effector T cells (Th1).